These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28373901)

  • 1. Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.
    Filippone SM; Samidurai A; Roh SK; Cain CK; He J; Salloum FN; Kukreja RC; Das A
    Oxid Med Cell Longev; 2017; 2017():4619720. PubMed ID: 28373901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
    Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
    Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
    Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
    J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.
    Samidurai A; Roh SK; Prakash M; Durrant D; Salloum FN; Kukreja RC; Das A
    Cardiovasc Res; 2020 Nov; 116(13):2103-2115. PubMed ID: 31738412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway.
    Das A; Salloum FN; Durrant D; Ockaili R; Kukreja RC
    J Mol Cell Cardiol; 2012 Dec; 53(6):858-69. PubMed ID: 22999860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart.
    Ma LL; Ma X; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
    J Cell Mol Med; 2018 Mar; 22(3):1708-1719. PubMed ID: 29314656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress.
    Ma LL; Li Y; Yin PP; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
    Clin Sci (Lond); 2018 Jan; 132(1):93-110. PubMed ID: 29175946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
    Samidurai A; Salloum FN; Durrant D; Chernova OB; Kukreja RC; Das A
    Br J Pharmacol; 2017 Dec; 174(24):4771-4784. PubMed ID: 28967097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
    Thomas CJ; Lim NR; Kedikaetswe A; Yeap YY; Woodman OL; Ng DC; May CN
    Eur J Pharmacol; 2015 Jul; 758():53-9. PubMed ID: 25820159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway.
    Xiao Y; Chen W; Zhong Z; Ding L; Bai H; Chen H; Zhang H; Gu Y; Lu S
    Biomed Pharmacother; 2020 Jul; 127():110148. PubMed ID: 32344255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of transient receptor potential vanilloid 1 protects the heart against apoptosis in ischemia/reperfusion injury through upregulating the PI3K/Akt signaling pathway.
    Jiang XX; Liu GY; Lei H; Li ZL; Feng QP; Huang W
    Int J Mol Med; 2018 Mar; 41(3):1724-1730. PubMed ID: 29286076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats.
    Kim SJ; Li M; Jeong CW; Bae HB; Kwak SH; Lee SH; Lee HJ; Heo BH; Yook KB; Yoo KY
    Arch Pharm Res; 2014 Aug; 37(8):1079-85. PubMed ID: 24307060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning.
    Hausenloy DJ; Mocanu MM; Yellon DM
    Cardiovasc Res; 2004 Aug; 63(2):305-12. PubMed ID: 15249188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA‑21 expression, Akt and the Bcl‑2/Bax pathway.
    Ma N; Bai J; Zhang W; Luo H; Zhang X; Liu D; Qiao C
    Mol Med Rep; 2016 Nov; 14(5):4216-4222. PubMed ID: 27666568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
    Loverre A; Ditonno P; Crovace A; Gesualdo L; Ranieri E; Pontrelli P; Stallone G; Infante B; Schena A; Di Paolo S; Capobianco C; Ursi M; Palazzo S; Battaglia M; Selvaggi FP; Schena FP; Grandaliano G
    J Am Soc Nephrol; 2004 Oct; 15(10):2675-86. PubMed ID: 15466272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
    Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
    Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.